Japanese Study Looks at Rates of Cancer Therapy–Related AML - Summary - MDSpire
From the Journals

Japanese Study Looks at Rates of Cancer Therapy–Related AML

A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia (AML) in recent years—especially after breast cancer treatment. 

Share

A recent population-based study from Japan indicates a concerning rise in therapy-related acute myeloid leukemia (tAML) among cancer survivors, particularly after breast cancer treatment. The analysis of data from the Osaka Cancer Registry, involving nearly 10,000 patients diagnosed with AML between 1990 and 2020, found tAML incidence rates increased from 0.13 to 0.36 per 100,000 population. The study highlights the changing landscape of tAML development and calls for increased awareness as cancer survivorship grows, according to lead author Kenji Kishimoto, MD, PhD.

Original Source(s)

Japanese Study Looks at Rates of Cancer Therapy–Related AML

  • by The ASCO Post Staff

  • April 9, 2026

Related Content

In Celebration of a Decades-Long Journey of Discovery and Innovation

On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs

“The evidence from our study implicates cannabis as a potential etiologic factor contributing to the rising incidence of breast cancer in young females and testis cancer in older adolescent and young ...

Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis

Results from a small phase II study suggest that a triplet regimen may improve symptoms and extend survival in some patients with breast cancer and leptomeningeal metastasis, who often face limited tr...